Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07PSF
|
||||
Former ID |
DIB018901
|
||||
Drug Name |
aspirin triggered lipoxin A4
|
||||
Synonyms |
aspirin-triggered lipoxin A4; ATL; aspirin triggered 15-epi lipoxin A4
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540556] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H32O5
|
||||
InChI |
InChI=1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18-,19+/m1/s1
|
||||
InChIKey |
IXAQOQZEOGMIQS-JEWNPAEBSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | FMLP-related receptor I | Target Info | Agonist | [543579] | |
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.